NANOCORT

Enceladus Pharmaceuticals B.V.

Trademark Registered: 2016-06-21
Trademark Application Details
Trademark Logo NANOCORT
700
Live/Registered
REGISTERED
Research OneLook Acronym Finder
Serial Number86247236
Registration Number4980589
Mark Drawing Code4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Domestic RepresentativeMichelle L. Zimmermann
Attorney NameMichelle L. Zimmermann
Attorney Docket Number282813
Law Office AssignedL50
Employee NameASKEW, MEGAN RUTH

Timeline

2014-04-09Application Filed
2014-10-21Published for Opposition
2016-06-21Location: PUBLICATION AND ISSUE SECTION
2016-06-21Status: Live/Registered
2016-06-21Trademark Registered
2018-07-08Transaction Date

Trademark Applicants & Owners

Owner: Enceladus Pharmaceuticals B.V.
Entity Statementbesloten vennootschap (b.v.)
AddressSumatrastraat 32 III 1094 ND Amsterdam NL
Legal Entity Type
Legal Entity State NL

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Michelle L. Zimmermann
Leydig, Voit & Mayer, Ltd.
Two Prudential Plaza, 180 N. Stetson Ave
Suite 4900
Chicago, IL 60601-6731

Good, Services, and Codes

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical and veterinary preparations for the treatment of inflammatory and immune disorders and conditions, namely, conditions of the bowel, kidneys, pancreas and liver, the group of vasculitis diseases, namely, Wegener's, Becet's, Kawasaki, Sle, transplant and allograft rejection, Graft versus Host disease (GvHD), arthritic and rheumatic diseases, multiple sclerosis, inflammatory bowel diseases and inflammatory conditions of the pancreas and liver, nephrology diseases, inflammatory conditions of the kidney, arteriovenous fistula failure, traumatic lesions, and for the treatment of cancer, all of the foregoing administered in hospitals by parenteral treatment; and all of the foregoing excluding any kind of product for the treatment of allergic rhinitis, and to the exclusion of anti-histamine products, respiratory products and any kind of product for the treatment of allergic rhinitis or respiratory conditions or diseases

Trademark Filing History

DescriptionDateEvent Coding
NEW APPLICATION ENTERED IN TRAM2014-04-121 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2014-04-212 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER2014-07-173 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN2014-07-224 CNRT R:Renewal
NON-FINAL ACTION E-MAILED2014-07-225 GNRT F:First Action
NOTIFICATION OF NON-FINAL ACTION E-MAILED2014-07-226 GNRN O:Outgoing Correspondence
TEAS RESPONSE TO OFFICE ACTION RECEIVED2014-08-217 TROA I:Incoming Correspondence
ASSIGNED TO LIE2014-08-278 ALIE A:Allowance for Publication
CORRESPONDENCE RECEIVED IN LAW OFFICE2014-09-099 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED2014-09-0910 TEME I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER2014-09-1511 CNSA O:Outgoing Correspondence
LAW OFFICE PUBLICATION REVIEW COMPLETED2014-09-1512 PREV O:Outgoing Correspondence
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2014-10-0113 NONP E:E-Mail
PUBLISHED FOR OPPOSITION2014-10-2114 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2014-10-2115 NPUB E:E-Mail
EXTENSION OF TIME TO OPPOSE RECEIVED2014-11-0716 ETOF T:TTAB Proceeding
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2015-01-1617 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2015-01-1618 ARAA I:Incoming Correspondence
TEAS POST PUBLICATION AMENDMENT RECEIVED2015-04-1619 EPPA I:Incoming Correspondence
ASSIGNED TO PETITION STAFF2015-04-2720 APET A:Allowance for Publication
CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED2015-04-2921 CHPB I:Incoming Correspondence
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED2015-05-0522 ETOP T:TTAB Proceeding
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED2015-05-1523 ERRR O:Outgoing Correspondence
PREVIOUS ALLOWANCE COUNT WITHDRAWN2015-09-1024 ZZZX Z:Deletion
NON-FINAL ACTION WRITTEN2015-09-2325 CNRT R:Renewal
NON-FINAL ACTION E-MAILED2015-09-2326 GNRT O:Outgoing Correspondence
NOTIFICATION OF NON-FINAL ACTION E-MAILED2015-09-2327 GNRN O:Outgoing Correspondence
TEAS RESPONSE TO OFFICE ACTION RECEIVED2015-11-0628 TROA I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE2015-11-1329 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED2015-11-1330 TEME I:Incoming Correspondence
ELECTRONIC RECORD REVIEW COMPLETE2015-11-1931 FIXD O:Outgoing Correspondence
WITHDRAWN FROM ISSUE - EXAMINING ATTORNEY REQUEST2015-11-2032 ISER Z:Deletion
TEAS RESPONSE TO OFFICE ACTION RECEIVED2016-03-0233 TROA I:Incoming Correspondence
REVIEW OF CORRESPONDENCE COMPLETE2016-05-2434 CORV P:
REGISTERED-PRINCIPAL REGISTER2016-06-2135 R.PR A:Allowance for Publication
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED2021-06-2136 REM1 E:E-Mail
CANCELLED SEC. 8 (6-YR)2023-01-0637 C8.. O:Outgoing Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed